GILD

Gilead Sciences Inc

May 21 • 03:37PM ET

130.95

+0.26 0.20 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: BMY PFE ABBV MRK AZN NVS LLY SNY AMGN TAK

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.82	EPS (ttm)	7.35	Insider Own	0.14%	Shs Outstand	1.24B	Perf Week	-0.84%
Market Cap	162.59B	Forward P/E	13.60	EPS next Y	9.63	Insider Trans	-18.44%	Shs Float	1.24B	Perf Month	-1.47%
Enterprise Value	174.86B	PEG	1.52	EPS next Q	-6.59	Inst Own	88.83%	Short Float	1.86%	Perf Quarter	-13.51%
Income	9.22B	P/S	5.46	EPS this Y	-96.79%	Inst Trans	-0.18%	Short Ratio	3.76	Perf Half Y	2.97%
Sales	29.79B	P/B	6.92	EPS next Y	3577.44%	ROA	16.35%	Short Interest	23.05M	Perf YTD	6.69%
Book/sh	18.93	P/C	16.56	EPS next 5Y	8.94%	ROE	43.19%	52W High	157.29 -16.74%	Perf Year	21.57%
Cash/sh	7.91	P/FCF	15.89	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	104.46 25.36%	Perf 3Y	66.09%
Dividend Est.	3.25 (2.48%)	EV/EBITDA	11.84	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	2.29% 2.36%	Perf 5Y	90.48%
Dividend TTM	3.19 (2.44%)	EV/Sales	5.87	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.14	Perf 10Y	58.46%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	43.55	Recom	1.59
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-0.48%	Beta	0.33	Target Price	160.73
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-3.77%	Rel Volume	0.43	Prev Close	130.69
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	2.15%	Avg Volume	6.13M	Price	130.95
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	2,462,218	Change	0.20%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)